Addition of Strategic Fort Myers Location Brings Total Number of Dispensaries Set to Open in First Half of 2018 to Five
TORONTO, Jan. 16, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) announced today that it has opened its inaugural medical cannabis dispensary in Florida, strategically located in The Villages, the state's largest retirement community. The Company also announced plans for a fifth Florida location in Fort Myers to open in early 2018, joining previously announced dispensaries opening in the first half of this year in Fort Lauderdale, St. Petersburg and Port. St. Lucie.
"It is with much anticipation that Liberty opens the Cannabis Education Center in The Villages, our first of many planned medical cannabis dispensaries in the State of Florida. Since day one, we have had an unwavering commitment to serving Floridians in need and this marks a very exciting next step in that journey," said George Scorsis, Director and CEO of Liberty Health Sciences. "In addition to offering access to high quality, safe and pure medical cannabis, the Cannabis Education Center will provide exceptional patient care through its comprehensive educational platform which includes tools, resources and compassionate one-on-one consultations geared towards educating patients on cannabis use as a safe alternative to treat their symptoms."
Liberty is also pleased to announce that its fifth Florida Cannabis Education Center will be strategically located in Fort Myers. With approximately 63,900 medical cannabis patients registered with the state, Liberty dispensary locations in Florida are chosen based on the needs of the local patient population and the number of prescribing physicians in the vicinity. "The Cannabis Education Center will be centrally located within the city to best serve the needs of the Fort Myers community," Scorsis said. "When it opens early this year, we will be able to offer even more Floridians convenient and affordable access to high-quality medical cannabis when and where they need it the most."
All Liberty locations in Florida will offer a wide variety of products and brands such as Aphria and Mary's Medicinals, providing patients in need with a variety of options to meet their needs across all state-approved methods of cannabis consumption including vapes, oils, tinctures and capsules.
Liberty's dispensary operations and plans are subject to final approval from the Florida Department of Health's Office of Medical Marijuana Use.
For more information on Liberty please visit www.libertyhealthsciences.com
About Liberty Health Sciences Inc.
Liberty Health Sciences Inc. ("Liberty") is an investor and operator in the medical cannabis market, capitalizing on new and existing opportunities in U.S. states where medical cannabis is legal. Liberty's stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near- and mid-term opportunities. Liberty has an extensive background in highly regulated industries, with expertise in becoming a low-cost producer. Liberty leverages commercial greenhouse knowledge to deliver high-quality, clean and safe pharmaceutical grade cannabis to patients.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "believe", "plan", "intend" or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, expectations related to the Company's future expansion and growth strategies, the expected timing concerning the opening of dispensaries, the receipt of final approval of Liberty's dispensary operations and plans from the Florida Department of Health's Office of Medical Marijuana Use and the Company's expectations in respect of the future growth of medical cannabis as a treatment option in Florida. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the medical marijuana industry in the United States generally, income tax and regulatory matters; the ability of Liberty to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks.
Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
SOURCE Liberty Health Sciences Inc.
For further information: For Canadian media inquiries, please contact: Matt Salvatore, Edelman, (613) 315-7362, [email protected]; For U.S. media inquiries, please contact: David Schull or Nic Johnson, Russo Partners, (858) 717-2310, [email protected], [email protected]